MGIM
LGND icon

M&G Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

M&G Investment Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,102
Closed -$1.22K – 632
2021
Q3 		$1.22K Sell
14,102
-7,431
-35% -$575K ﹤0.01% 602
2021
Q2 		$1.76K Buy
+21,533
New +$1.79M ﹤0.01% 523

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

M&G Investment Management's LGND Position: Q4 2021 in Review

M&G Investment Management sold out of Ligand Pharmaceuticals (LGND) in Q4 2021, closing a stake of 14,102 shares — an estimated $1.22K sold.

M&G Investment Management first reported a position in LGND in Q2 2021 and held it in 2 quarters. The position peaked at $1.76K in Q2 2021. 221 funds tracked by Wall St. Rank hold LGND as of Q4 2021.

  • M&G Investment Management reported no remaining Ligand Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 14,102 Ligand Pharmaceuticals shares in Q4 2021, an estimated $1.22K.
  • M&G Investment Management first reported a position in Ligand Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Ligand Pharmaceuticals position peaked at $1.76K in Q2 2021.
  • 221 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.